Wen et al. found that triple negative breast cancers present high levels of ID4 protein respect to the other breast cancers and propose that overexpression of ID4 could functionally inactivate BRCA1 in this tumor type which presents characteristics similar to BRCA1-mutant tumors and downregulation of BRCA1 [45]. This evidence concerns the gene ID4 and triple-negative breast carcinoma.